{"id":861644,"date":[{"year":1992,"month":3,"day":6}],"page":"3","source":"本报","region":"","masthead":"科教文卫新闻","special_issue":"","column":"","genre":"","count":"158","ytitle":"上海交大开发“昂立一号”口服液","mtitle":"对癌症患者有辅助疗效","ftitle":"","authors":["张自强"],"text":[{"type":"paragraph","text":"本报讯　(记者张自强)上海交通大学生物科学与技术系的研究人员，在国际上首次筛选、发现一种以“onlyi”为名字的微生物菌株对人体具有独特的功效，用这种菌株开发研制的“昂立一号”口服液能够显著增强动物免疫机能，对于肝癌等癌症患者具有明显的辅助治疗作用。"}]}